Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Abrams, Steven" or (type any "bookEditor issueEditor" and editor="Abrams, Steven")

Add to list
- Journal Article
- open access
Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients

Christel Faes, Steven Abrams, Dominique Van Beckhoven, Geert Meyfroidt, Erika Vlieghe, Niel Hens and [missing] Belgian Collaborative Group on COVID-19 Hospital Surveillance Belgian Collaborative Group on COVID-19 Hospital Surveillance

(2020) International Journal of Environmental Research and Public Health.
Add to list
- Journal Article
- A1
- open access
Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic : perspective from a European country

Geert Molenberghs, Marc Buyse, Steven Abrams, Niel Hens, Philippe Beutels, Christel Faes, Geert Verbeke, Pierre Van Damme, Herman Goossens, Thomas Neyens, et al.

(2020) CONTEMPORARY CLINICAL TRIALS. 99.
Add to list
- Journal Article
- A1
- open access
The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006 : a comparative analysis with hepatitis A virus seroprevalence

Suzanne Smit (UGent) , Steven Abrams, Pierre Dorny (UGent) , Niko Speybroeck, Brecht Devleesschauwer (UGent) , Veronik Hutse, Hilde Jansens, Heidi Theeten, Philippe Beutels and Niel Hens

(2019) EPIDEMIOLOGY AND INFECTION. 147.
Add to list
The efficacy and safety of onabotulinumtoxinA or solifenacin compared with placebo in solifenacin-naïve patients with refractory overactive bladder : results from a multicenter, randomized, double-blind, phase 3b trial

Sender Herschorn, Alfred Kohan, Philip Aliotta, Kurt McCammon, Rajagopalan Sriram, Steven Abrams, Wayne Lam and Karel Everaert (UGent)

(2017) JOURNAL OF UROLOGY. 198(1). p.167-175

Academic Bibliography

Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients

Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic : perspective from a European country

The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006 : a comparative analysis with hepatitis A virus seroprevalence

The efficacy and safety of onabotulinumtoxinA or solifenacin compared with placebo in solifenacin-naïve patients with refractory overactive bladder : results from a multicenter, randomized, double-blind, phase 3b trial

Contents

Support

Contact